Bcl-xL-directed oligonucleotides in prostate and bladder carcinoma cell lines

Antisense and Nucleic Acid Drug Development

Volumn 9, Issue 4, 1999, Pages 381-382

  Lebedeva, Irina V ^a   Stein, C A ^a  

^a The New York Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000447935     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. BENMETSKAYA, L., TAKLE, G.B., VILENCHIK, M., LEBEDEVA, I., MILLER, P.,and STEIN, C.A. (1998). Cationic porphyrins: Novel delivery vehicles for antisense oligodeoxynucleotides. Nucleic Acids Res. 26, 5310-5317.
2. DEAN, N.M., McKAY, R., CONDON, T.R., BENNETT, C.F., et al. (1994). Inhibition of protein kinase C-a expression in human A549 cells by antisense oligonucleotides inhibits induction of intracellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J. Biol. Chem. 269, 16416-16424.
3. KRAJEWSKA, M., KRAYEWSKI, S., EPSTEIN, J.I., SHABAIK, A., SAUVAGEOT, J., SONG, K., KITADA, S., and REED, J.C. (1996). Immunohistochemical analysis of bcl-2, bax, bcl-xL, and mcl-1 expressions in prostate cancers. Am. I. Pathol. 148, 1567-1576.
4. MONIA, B.P., JOHNSTON, J.F., GEIGER, T., MULLER, M.,and FABBRO, D. (1996). Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-ra/kinase. Nat. Med. 2, 668-675.
5. REED, J.C. (1994). Bcl-2 and the regulation of programmed cell death. J. Cell. Biol. 1-2, 1-6.
6. REED, J.C. MIYASHITA, T., TAKAYAMA, S., WANG, H-G., SATO, T., KRAJEWSKI, S., AME-SEMPE, C., BODRUG, S., KITADA, S.,and HANADA, M. (1996). Bcl-2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J. Cell. Biochem. 60, 23-32.
7. STELLER, H. (1995). Mechanisms and genes of cellular suicide. Science 267, 1445-1449.